Анализ положений рекомендаций Американского общества гастроинтестинальной эндоскопии по скринингу и наблюдению пациентов с пищеводом Барретта

Закрыть метаданные

Цель исследования — проанализировать положения рекомендаций Американского общества гастроинтестинальной эндоскопии (American Society for Gastrointestinal Endoscopy — ASGE) по скринингу и наблюдению пациентов с пищеводом Барретта. В рекомендациях рассматриваются ключевые клинические вопросы, касающиеся скрининга, наблюдения и эффективности современных технологий визуализации и верификации, таких как хромоскопия, волюметрическая лазерная эндомикроскопия, конфокальная лазерная эндомикроскопия, эндосонография, обширный трансэпителиальный забор материала.

Ключевые слова:

пищевод Барретта

аденокарцинома пищевода

гастроэзофагеальная рефлюксная болезнь

скрининг

эндоскопия

Авторы:

Куваев Р.О.

Никонов Е.Л.

ФГБУ "Поликлиника №1" Управления делами Президента РФ

Видяева Н.С.

ГБУЗ Ярославской области «Клиническая онкологическая больница», Ярославль, Россия

Кашин С.В.

Жарова М.Е.

ФГБУО ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России, Москва, Россия; ГБУ «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента Департамента здравоохранения Москвы», Москва, Россия

Список литературы:

Wani S, Sultan S, Qumseya B, Michalek J, Dewitt J, Edmundowicz SA, Woods KL. The ASGE’S vision for developing clinical practice guidelines: the path forward. Gastrointestinal Endoscopy. 2018;87(4):932-933. https://doi.org/10.1016/j.gie.2017.10.012
Wani S, Qumseya B, Sultan S, Agrawal D, Chandrasekhara V, Harnke B, Kothari S, McCarter M, Shaukat A, Wang A, Yang J, Dewitt J. Endoscopic eradication therapy for patients with Barrett’s esophagus-associated dysplasia and intramucosal cancer. Gastrointestinal Endoscopy. 2018;87(4):907-931. https://doi.org/10.1016/j.gie.2017.10.011
Кашин С.В., Видяева Н.С., Куваев Р.О., Крайнова Е.А., Хайдри Р., Рагунат К., Маннер Х. Лечение пациентов с пищеводом Баррета. Доказательная гастроэнтерология. 2017;6(4):59-77. https://doi.org/10.17116/dokgastro20176459-77
Никонов Е.Л., Куваев Р.О., Кашин С.В. Пищевод Барретта: современные возможности медикаментозного лечения и новые методики эндоскопической терапии. Доказательная гастроэнтерология. 2014;3(3):19-24. https://doi.org/10.17116/dokgastro2017644-19
Wani S, Rubenstein JH, Vieth M, Bergman J. Diagnosis and Management of Low-Grade Dysplasia in Barrett’s Esophagus: Expert Review from the Clinical Practice Updates Committee of the American Gastroenterological Association. Gastroenterology. 2016;151(5):822-835. https://doi.org/10.1053/j.gastro.2016.09.040
Shaheen NJ, Falk GW, Iyer PG, Gerson LB; Gastroenterology ACo. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. American Journal of Gastroenterology. 2016;111(1):30-50. https://doi.org/10.1038/ajg.2015.322
Thrift AP. Barrett’s Esophagus and Esophageal Adenocarcinoma: How Common Are They Really? Digestive Diseases and Sciences. 2018;63(8):1988-1996. https://doi.org/10.1007/s10620-018-5068-6
Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149(2):302-317. https://doi.org/10.1053/j.gastro.2015.04.053
Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149-1158. https://doi.org/10.1002/cncr.27834
Ronkainen J, Aro P, Storskrubb T, Johansson S, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agréus L. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825-1831. https://doi.org/10.1053/j.gastro.2005.08.053
Vennalaganti PR, Kaul V, Wang KK, Falk GW, Shaheen NJ, Infantolino A, Johnson DA, Eisen G, Gerson LB, Smith MS, Iyer PG, Lightdale CJ, Schnoll-Sussman F, Gupta N, Gross SA, Abrams J, Haber GB, Chuttani R, Pleskow DK, Kothari S, Goldblum JR, Zhang Y, Sharma P. Increased detection of Barrett’s esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial. Gastrointestinal Endoscopy. 2018;87(2):348-355. https://doi.org/10.1016/j.gie.2017.07.039
Small AJ, Araujo JL, Leggett CL, Mendelson AH, Agarwalla A, Abrams JA, Lightdale, CJ, Wang TC, Iyer PG, Wang KK, Rustgi AK, Ginsberg GG, Forde KA, Gimotty PA, Lewis JD, Falk GW, Bewtra M. Radiofrequency Ablation is Associated with Decreased Neoplastic Progression in Patients with Barrett’s Esophagus and Confirmed Low-Grade Dysplasia. Gastroenterology. 2015;149(3):567-576.
Qumseya BJ, Wani S, Gendy S, Harnke B, Bergman JJ, Wolfsen H. Disease Progression in Barrett’s Low-Grade Dysplasia with Radiofrequency Ablation Compared with Surveillance: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 2017;112(6):849-865. https://doi.org/10.1038/ajg.2017.70
Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ, Association AG. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):1084-1091. https://doi.org/10.1053/j.gastro.2011.01.031
Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O’Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7-42. https://doi.org/10.1136/gutjnl-2013-305372
Weusten B, Bisschops R, Coron E, Dinis-Ribeiro M, Dumonceau J, Esteban J, Hassan C, Pech O, Repici A, Bergman J, di Pietro M. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49(2):191-198. https://doi.org/10.1055/s-0042-122140
Saxena N, Inadomi JM. Effectiveness and Cost-Effectiveness of Endoscopic Screening and Surveillance. Gastrointestinal Endoscopy Clinics of North America. 2017;27(3):397-421. https://doi.org/10.1016/j.giec.2017.02.005
Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, Agrawal D, Buxbaum JL, Fishman DS, Gurudu SR, Jue TL, Kripalani S, Lee JK, Khashab MA, Naveed M, Thosani NC, Yang J, DeWitt J, Wani S. ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointestinal Endoscopy. 2019;90(3):335-359.e332. https://doi.org/10.1016/j.gie.2019.05.012
Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG. The Effect of Endoscopic Surveillance in Patients with Barrett’s Esophagus: A Systematic Review and Meta-analysis. Gastroenterology. 2018;154(8):2068-2086.e2065. https://doi.org/10.1053/j.gastro.2018.02.022
El-Serag HB, Naik AD, Duan Z, Shakhatreh M, Helm A, Pathak A, Hinojosa-Lindsey M, Hou J, Nguyen T, Chen J, Kramer JR. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett’s oesophagus. Gut. 2016;65(8):1252-1260. https://doi.org/10.1136/gutjnl-2014-308865
Tramontano AC, Sheehan DF, Yeh JM, Kong C, Dowling E, Rubenstein J, Abrams J, Inadomi J, Schrag D, Hur C. The Impact of a Prior Diagnosis of Barrett’s Esophagus on Esophageal Adenocarcinoma Survival. American Journal of Gastroenterology. 2017;112(8):1256-1264. https://doi.org/10.1038/ajg.2017.82
Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Annals of Internal Medicine. 2003;138(3):176-186. https://doi.org/10.7326/0003-4819-138-3-200302040-00009
Nietert PJ, Silverstein MD, Mokhashi MS, Kim CY, Glenn TF, Marsi VA, Hawes RH, Wallace MB. Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointestinal Endoscopy. 2003;57(3):311-318. https://doi.org/10.1067/mge.2003.101
Gerson L, Lin OS. Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett’s esophagus. Clinical Gastroenterology and Hepatology. 2007;5(3):319-325. https://doi.org/10.1016/j.cgh.2006.12.022
Gerson LB, Groeneveld PW, Triadafilopoulos G. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Clinical Gastroenterology and Hepatology. 2004;2(10):868-879. https://doi.org/10.1016/S1542-3565(04)00394-5
Rubenstein JH, Inadomi JM, Brill JV, Eisen GM. Cost utility of screening for Barrett’s esophagus with esophageal capsule endoscopy versus conventional upper endoscopy. Clinical Gastroenterology and Hepatology. 2007;5(3):312-318. https://doi.org/10.1016/j.cgh.2006.12.008
Rubenstein JH, Inadomi JM. Defining a clinically significant adverse impact of diagnosing Barrett’s esophagus. Journal of Clinical Gastroenterology. 2006;40(2):109-115. https://doi.org/10.1097/01.mcg.0000196186.19426.4a
Old O, Moayyedi P, Love S, Roberts C, Hapeshi J, Foy C, Stokes Cl, Briggs A, Jankowski J, Barr H. Barrett’s Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial. Journal of Medical Screening. 2015;22(3):158-164. https://doi.org/10.1177/0969141315575052
Ben-Menachem T, Decker GA, Early DS, Evans J, Fanelli RD, Fisher DA, Fisher L, Fukami N, Hwang JH, Ikenberry SO, Jain R, Jue TL, Khan KM, Krinsky ML, Malpas PM, Maple JT, Sharaf RN, Dominitz JA, Cash BD. Adverse events of upper GI endoscopy. Gastrointestinal Endoscopy. 2012;76(4):707-718. https://doi.org/10.1016/j.gie.2012.03.252
Qumseya BJ, Wani S, Desai M, Qumseya A, Bain P, Sharma P, Wolfsen H. Adverse Events After Radiofrequency Ablation in Patients with Barrett’s Esophagus: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2016;14(8):1086-1095.e1086. https://doi.org/10.1016/j.cgh.2016.04.001
Evans JA, Early DS, Fukami N, Ben-Menachem T, Chandrasekhara V, Chathadi KV, Decker GA, Fanelli RD, Fisher DA, Foley KQ, Hwang JH, Jain R, Jue TL, Khan KM, Lightdale J, Malpas PM, Maple JT, Pasha SF, Saltzman JR, Sharaf RN, Shergill A, Dominitz JA, Cash BD. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointestinal Endoscopy. 2012;76(6):1087-1094. https://doi.org/10.1016/j.gie.2012.08.004
Wani S, Falk G, Hall M, Gaddam S, Wang A, Gupta N, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Reddymasu S, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Lieberman DA, Sampliner RE, Sharma P. Patients with nondysplastic Barrett’s esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clinical Gastroenterology and Hepatology. 2011;9(3):220-227. https://doi.org/10.1016/j.cgh.2010.11.008
Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. New England Journal of Medicine. 2011;365(15):1375-1383. https://doi.org/10.1056/NEJMoa1103042
Desai TK, Krishnan K, Samala N, Desai TK, Krishnan K, Samala N, Singh J, Cluley J, Perla S, Howden CW. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61(7):970-976. https://doi.org/10.1136/gutjnl-2011-300730
Abela JE, Going JJ, Mackenzie JF, McKernan M, O’Mahoney S, Stuart RC. Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than nonsystematic biopsy. American Journal of Gastroenterology. 2008;103(4):850-855. https://doi.org/10.1111/j.1572-0241.2007.01746.x
Wani S, Gaddam S. Editorial: Best Practices in Surveillance of Barrett’s Esophagus. American Journal of Gastroenterology. 2017;112(7):1056-1060. https://doi.org/10.1038/ajg.2017.117
Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. American Journal of Gastroenterology. 2000;95(11):3089-3096. https://doi.org/10.1111/j.1572-0241.2000.03182.x
Fitzgerald RC, Saeed IT, Khoo D, Farthing MJ, Burnham WR. Rigorous surveillance protocol increases detection of curable cancers associated with Barrett’s esophagus. Digestive Diseases and Sciences. 2001;46(9):1892-1898. https://doi.org/10.1023/A:1010678913481
Abrams JA, Kapel RC, Lindberg GM, Saboorian MH, Genta RM, Neugut AI, Lightdale CJ. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clinical Gastroenterology and Hepatology. 2009;7(7):736-742. https://doi.org/10.1016/j.cgh.2008.12.027
Wani S, Keswani RN, Petersen B, Edmundowicz SA, Walsh CM, Huang C, Cohen J, Cote G. Training in EUS and ERCP: standardizing methods to assess competence. Gastrointestinal Endoscopy. 2018;87(6):1371-1382. https://doi.org/10.1016/j.gie.2018.02.009
Wani S, Mathur SC, Curvers WL, Singhlow V, Herrero LA, Hall SB, Ulusarac O, Cherian R, McGregor DH, Bansal A, Rastogi A, Ahmed B, Singh M, Gaddam S, Ten Kate FJ, Bergman J, Sharma P. Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett’s dysplasia. Clinical Gastroenterology and Hepatology. 2010;8(9):783-788. https://doi.org/10.1016/j.cgh.2010.04.028
Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, Gupta N, Gaddam S, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Goldblum J, Lieberman DA, Sampliner RE, Sharma P. Risk factors for progression of low-grade dysplasia in patients with Barrett’s esophagus. Gastroenterology. 2011;141(4):1179-1186. https://doi.org/10.1053/j.gastro.2011.06.055
Curvers WL, ten Kate FJ, Krishnadath KK, Visser M, Elzer B, Baak L, Bohmer C, Mallant-Hent R, van Oijen A, Naber A, Scholten P, Busch O, Blaauwgeers H, Meijer G, Bergman J. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. American Journal of Gastroenterology. 2010;105(7):1523-1530. https://doi.org/10.1038/ajg.2010.171
Krishnamoorthi R, Singh S, Ragunathan K, Visrodia K, Wang KK, Katzka DA, Iyer PG. Factors Associated with Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2018;16(7):1046-1055.e1048. https://doi.org/10.1016/j.cgh.2017.11.044
Jankowski JAZ, de Caestecker J, Love SB, Reilly G, Watson P, Sanders S, Ang Y, Morris D, Bhandari P, Brooks C, Attwood S, Harrison R, Barr H, Moayyedi P. Esomeprazole and aspirin in Barrett’s oesophagus (AspECT): a randomised factorial trial. Lancet. 2018;392(10145):400-408. https://doi.org/10.1016/S0140-6736(18)31388-6
Thrift AP, Kendall BJ, Pandeya N, Whiteman DC. A model to determine absolute risk for esophageal adenocarcinoma. Clinical Gastroenterology and Hepatology. 2013;11(2):138-144.e132. https://doi.org/10.1016/j.cgh.2012.10.026
Bird-Lieberman EL, Dunn JM, Coleman HG, Lao-Sirieix P, Oukrif D, Moore CE, Varghese S, Johnston BT, Arthur K, McManus DT, Novelli MR, O’Donovan M, Cardwell CR, Lovat LB, Murray LJ, Fitzgerald RC. Population-based study reveals new risk-stratification biomarker panel for Barrett’s esophagus. Gastroenterology. 2012;143(4):927-935.e923. https://doi.org/10.1053/j.gastro.2012.06.041
Sato F, Jin Z, Schulmann K, Wang J, Greenwald BD, Ito T, Kan T, Hamilton JP, Yang J, Paun B, David S, Olaru A, Cheng Y, Mori Y, Abraham JM, Yfantis HG, Wu TT, Fredericksen MB, Wang KK, Canto M, Romero Y, Feng Z, Meltzer SJ. Three-tiered risk stratification model to predict progression in Barrett’s esophagus using epigenetic and clinical features. PLoS One. 2008;3(4):e1890. https://doi.org/10.1371/journal.pone.0001890
Parasa S, Vennalaganti S, Gaddam S, Vennalaganti P, Young P, Gupta N, Thota P, Cash B, Mathur S, Sampliner R, Moawad F, Lieberman D, Bansal A, Kennedy KF, Vargo J, Falk G, Spaander M, Bruno M, Sharma P. Development and Validation of a Model to Determine Risk of Progression of Barrett’s Esophagus to Neoplasia. Gastroenterology. 2018;154(5):1282-1289.e1282. https://doi.org/10.1053/j.gastro.2017.12.009
Taylor JB, Rubenstein JH. Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett’s esophagus. American Journal of Gastroenterology. 2010;105(8):1729, 1730-1727. https://doi.org/10.1038/ajg.2010.194
Andrici J, Cox MR, Eslick GD. Cigarette smoking and the risk of Barrett’s esophagus: a systematic review and meta-analysis. Journal of Gastroenterology and Hepatology. 2013;28(8):1258-1273. https://doi.org/10.1111/jgh.12230
Singh S, Sharma AN, Murad MH, Buttar Navtej S., El-Serag HB, Katzka DA, Iyer PG. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. 2013;11(11):1399-1412.e1397. https://doi.org/10.1016/j.cgh.2013.05.009
Qumseya BJ, Bukannan A, Gendy S, Ahemd Y, Sultan S, Bain P, Gross SA, Iyer P, Wani S. Systematic review and meta-analysis of prevalence and risk factors for Barrett’s esophagus. Gastrointestinal Endoscopy. 2019;90(5):707-717. https://doi.org/10.1016/j.gie.2019.05.030
Gupta N, Bansal A, Wani SB, Gaddam S, Rastogi A, Sharma P. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. Gastrointestinal Endoscopy. 2011;74(3):610-624. https://doi.org/10.1016/j.gie.2011.05.001
Benaglia T, Sharples LD, Fitzgerald RC, Lyratzopoulos G. Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett’s esophagus. Gastroenterology. 2013;144(1):62-73. https://doi.org/10.1053/j.gastro.2012.09.060
Heberle CR, Omidvari AH, Ali A, Kroep S, Kong CY, Inadomi JM, Rubenstein JH, Tramontano CA, Dowling EC, Hazelton WD, Luebeck EG, Lansdorp-Vogelaar I, Hu C. Cost Effectiveness of Screening Patients with Gastroesophageal Reflux Disease for Barrett’s Esophagus with a Minimally Invasive Cell Sampling Device. Clinical Gastroenterology and Hepatology. 2017;15(9):1397-1404. https://doi.org/10.1016/j.cgh.2017.02.017
Inadomi JM, Saxena N. Screening and Surveillance for Barrett’s Esophagus: Is It Cost-Effective? Digestive Diseases and Sciences. 2018;63(8):2094-2104. https://doi.org/10.1007/s10620-018-5148-7
Spechler SJ, Katzka DA, Fitzgerald RC. New Screening Techniques in Barrett’s Esophagus: Great Ideas or Great Practice? Gastroenterology. 2018;154(6):1594-1601. https://doi.org/10.1053/j.gastro.2018.03.031
Bhat SK, McManus DT, Coleman HG, Johnston BT, Cardwell CR, McMenamin Ú, Bannon F, Hicks B, Kennedy G, Gavin AT, Murray LJ. Oesophageal adenocarcinoma and prior diagnosis of Barrett’s oesophagus: a population-based study. Gut. 2015;64(1):20-25. https://doi.org/10.1136/gutjnl-2013-305506
Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RKH, Vasudeva RS, Dunne D, Rahmani EY, Helper DJ. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125(6):1670-1677. https://doi.org/10.1053/j.gastro.2003.09.030
Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology. 2002;123(2):461-467. https://doi.org/10.1053/gast.2002.34748
Rubenstein JH, Morgenstern H, Appelman H, Scheiman J, Schoenfeld P, McMahon L, Metko V, Near E, Kellenberg J, Kalish T, Inadomi J. Prediction of Barrett’s esophagus among men. American Journal of Gastroenterology. 2013;108(3):353-362. https://doi.org/10.1038/ajg.2012.446
Ireland CJ, Gordon AL, Thompson SK, Watson DI, Whiteman DC, Reed RL, Esterman A. Validation of a risk prediction model for Barrett’s esophagus in an Australian population. Clinical and Experimental Gastroenterology. 2018;11:135-142. https://doi.org/10.2147/CEG.S158627
Ireland CJ, Fielder AL, Thompson SK, Laws TA, Watson DI, Esterman A. Development of a risk prediction model for Barrett’s esophagus in an Australian population. Diseases of the Esophagus. 2017;30(11):1-8. https://doi.org/10.1093/dote/dox033
Thrift AP, Kendall BJ, Pandeya N, Vaughan TL, Whiteman DC, Health SoD. A clinical risk prediction model for Barrett esophagus. Cancer Prevention Research. 2012;5(9):1115-1123. https://doi.org/10.1158/1940-6207.CAPR-12-0010
Rubenstein JH, Thrift AP. Risk factors and populations at risk: selection of patients for screening for Barrett’s oesophagus. Best Practice and Research Clinical Gastroenterology. 2015;29(1):41-50. https://doi.org/10.1016/j.bpg.2014.11.009
Mussetto A, Manno M, Fuccio L, Conigliaro R. Screening for Barrett’s oesophagus with oesophageal capsule endoscopy in first-degree relatives of patients affected by Barrett’s oesophagus: results of a pilot study. Arabian Journal of Gastroenterology. 2013;14(2):51-54. https://doi.org/10.1016/j.ajg.2013.03.003
Galmiche JP, Sacher-Huvelin S, Coron E, Cholet F, Soussan EB, Sébille V, Filoche B, d’Abrigeon G, Antonietti M, Robaszkiewicz M, Rhun ML, Ducrotté P. Screening for esophagitis and Barrett’s esophagus with wireless esophageal capsule endoscopy: a multicenter prospective trial in patients with reflux symptoms. American Journal of Gastroenterology. 2008;103(3):538-545. https://doi.org/10.1111/j.1572-0241.2007.01731.x
Chavalitdhamrong D, Chen GC, Roth BE, Goltzer O, Sul J, Jutabha R. Esophageal capsule endoscopy for evaluation of patients with chronic gastroesophageal reflux symptoms: findings and its image quality. Diseases of the Esophagus. 2011;24(5):295-298. https://doi.org/10.1111/j.1442-2050.2010.01136.x
Olliver JR, Wild CP, Sahay P, Dexter S, Hardie LJ. Chromoendoscopy with methylene blue and associated DNA damage in Barrett’s oesophagus. Lancet. 2003;362(9381):373-374. https://doi.org/10.1016/S0140-6736(03)14026-3
Kondo H, Fukuda H, Ono H, Gotoda T, Saito D, Takahiro K, Shirao K, Yamaguchi H, Yoshida S. Sodium thiosulfate solution spray for relief of irritation caused by Lugol’s stain in chromoendoscopy. Gastrointestinal Endoscopy. 2001;53(2):199-202. https://doi.org/10.1067/mge.2001.110730
Wani S, Sharma P. Endoscopic surface imaging of Barrett’s Esophagus: an optimistic view. Gastroenterology. 2007;133(1):11-13. https://doi.org/10.1053/j.gastro.2007.05.062
Sharma P, Bergman JJ, Goda K, Kato M, Messmann H, Alsop BR, Gupta N, Vennalaganti P, Hall M, Konda V, Koons A, Penner O, Goldblum JR, Waxman I. Development and Validation of a Classification System to Identify High-Grade Dysplasia and Esophageal Adenocarcinoma in Barrett’s Esophagus Using Narrow-Band Imaging. Gastroenterology. 2016;150(3):591-598. https://doi.org/10.1053/j.gastro.2015.11.037
Everson MA, Lovat LB, Graham DG, Bassett P, Magee C, Alzoubaidi D, Fernández-Sordo JO, Sweis R, Banks MR, Wani S, Esteban JM, Ragunath K, Bisschops R, Haidry RJ. Virtual chromoendoscopy by using optical enhancement improves the detection of Barrett’s esophagus-associated neoplasia. Gastrointestinal Endoscopy. 2019;89(2):247-256.e244. https://doi.org/10.1016/j.gie.2018.09.032
Qumseya BJ, Wang H, Badie N, Uzomba RN, Parasa S, White DL, Wolfsen H, Sharma P, Wallace MB. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett’s esophagus: a meta-analysis and systematic review. Clinical Gastroenterology and Hepatology. 2013;11(12):1562-1570.e1561-1562. https://doi.org/10.1016/j.cgh.2013.06.017
Thosani N, Abu Dayyeh BK, Sharma P, Harry RA, Enestvedt BK, Komanduri S, Manfredi M, Navaneethan U, Maple JT, Pannala R, Parsi MA, Smith ZL, Sullivan SA, Banerjee S. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for adopting real-time imaging-assisted endoscopic targeted biopsy during endoscopic surveillance of Barrett’s esophagus. Gastrointestinal Endoscopy. 2016;83(4):684-698.e687. https://doi.org/10.1016/j.gie.2016.01.007
Sharma P, Savides TJ, Canto MI, Corley DA, Falk GW, Goldblum JR, Wang KK, Wallace MB, Wolfsen HC. The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett’s Esophagus. Gastrointestinal Endoscopy. 2012;76(2):252-254. https://doi.org/10.1016/j.gie.2012.05.007
Bratlie SO, Johnsson E, Jönsson C, Fändriks L, Edebo A. Multiple-Band Imaging Provides Better Value Than White-light Endoscopy in Detection of Dysplasia in Patients with Barrett’s Esophagus. Clinical Gastroenterology and Hepatology. 2015;13(6):1068-1074.e1062. https://doi.org/10.1016/j.cgh.2014.12.007
Curvers WL, van Vilsteren FG, Baak LC, Böhmer C, Mallant-Hent RC, Naber AH, van Oijen A, Ponsioen CY, Scholten P, Schenk E, Schoon E, Seldenrijk A, Meijer GA, ten Kate FJ, Bergman JJ. Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett’s neoplasia: a multicenter, randomized, crossover study in general practice. Gastrointestinal Endoscopy. 2011;73(2):195-203. https://doi.org/10.1016/j.gie.2010.10.014
Sharma P, Hawes RH, Bansal A, Gupta N, Curvers W, Rastogi A, Singh M, Hall M, C Mathur SC, Wani SB, Hoffman B, Gaddam S, Fockens P, Bergman JJ. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut. 2013;62(1):15-21. https://doi.org/10.1136/gutjnl-2011-300962
Bhandari P, Kandaswamy P, Cowlishaw D, Longcroft-Wheaton G. Acetic acid-enhanced chromoendoscopy is more cost-effective than protocol-guided biopsies in a high-risk Barrett’s population. Diseases of the Esophagus. 2012;25(5):386-392. https://doi.org/10.1111/j.1442-2050.2011.01267.x
Xiong YQ, Ma SJ, Zhou JH, Zhong XS, Chen Q. A meta-analysis of confocal laser endomicroscopy for the detection of neoplasia in patients with Barrett’s esophagus. Journal of Gastroenterology and Hepatology. 2016;31(6):1102-1110. https://doi.org/10.1111/jgh.13267
Canto MI, Anandasabapathy S, Brugge W, Falk GW, Dunbar KB, Zhang Z, Woods K, Almario JA, Schell U, Goldblum J, Maitra A, Montgomery E, Kiesslich R. In vivo endomicroscopy improves detection of Barrett’s esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointestinal Endoscopy. 2014;79(2):211-221. https://doi.org/10.1016/j.gie.2013.09.020
Dunbar KB, Canto MI. Confocal laser endomicroscopy in Barrett’s esophagus and endoscopically inapparent Barrett’s neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointestinal Endoscopy. 2010;72(3):668. https://doi.org/10.1016/j.gie.2009.12.007
Sharma P, Meining AR, Coron E, Lightdale CJ, Wolfsen HC, Bansal A, Bajbouj M, Galmiche J, Abrams JA, Rastogi A, Gupta N, Michalek JE, Lauwers GY, Wallace MB. Real-time increased detection of neoplastic tissue in Barrett’s esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointestinal Endoscopy. 2011;74(3):465-472. https://doi.org/10.1016/j.gie.2011.04.004
Bertani H, Frazzoni M, Dabizzi E, Pigò F, Losi L, Manno M, Manta R, Bassotti G, Conigliaro R. Improved detection of incident dysplasia by probe-based confocal laser endomicroscopy in a Barrett’s esophagus surveillance program. Digestive Diseases and Sciences. 2013;58(1):188-193. https://doi.org/10.1007/s10620-012-2332-z
Machicado JD, Han S, Yadlapati RH, Simon VC, Qumseya BJ, Sultan S, Kushnir VM, Komanduri S, Rastogi A, Muthusamy VR, Haidry R, Ragunath K, Singh R, Hammad HT, Shaheen NJ, Wani S. A Survey of Expert Practice and Attitudes Regarding Advanced Imaging Modalities in Surveillance of Barrett’s Esophagus. Digestive Diseases and Sciences. 2018;63(12):3262-3271. https://doi.org/10.1007/s10620-018-5257-3
Committee AT. Confocal laser endomicroscopy. Gastrointestinal Endoscopy. 2014;80(6):928-938. https://doi.org/10.1016/j.gie.2014.06.021
Wallace MB, Meining A, Canto MI, Fockens P, Miehlke S, Roesch T, Lightdale CJ, Pohl H, Carr-Locke D, Löhr M, Coron E, Filoche B, Giovannini M, Moreau J, Schmidt C, Kiesslich R. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Alimentary Pharmacology and Therapeutics. 2010;31(5):548-552. https://doi.org/10.1111/j.1365-2036.2009.04207.x
Saumoy M, Schneider Y, Novikov AA, Tyberg A, Kahaleh M, Sharaiha RZ. Cost-Utility Analysis for Surveillance of Barrett’s Esophagus Evaluating Standard Biopsies Compared to Optical Coherence Tomography and Confocal Laser Endomicroscopy. Gastrointestinal Endoscopy. 2017;85(5):AB559-AB560. https://doi.org/10.1016/j.gie.2017.03.1291
Qumseya BJ, Brown J, Abraham M, White D, Wolfsen H, Gupta N, Vennalaganti P, Sharma P, Wallace MB. Diagnostic performance of EUS in predicting advanced cancer among patients with Barrett’s esophagus and high-grade dysplasia/early adenocarcinoma: systematic review and meta-analysis. Gastrointestinal Endoscopy. 2015;81(4):865-874.e862. https://doi.org/10.1016/j.gie.2014.08.025
Qumseya BJ, Bartel MJ, Gendy S, Bain P, Qumseya A, Wolfsen H. High rate of over-staging of Barrett’s neoplasia with endoscopic ultrasound: Systemic review and meta-analysis. Digestive and Liver Disease. 2018;50(5):438-445. https://doi.org/10.1016/j.dld.2018.02.005
Thota PN, Sada A, Sanaka MR, Jang S, Lopez R, Goldblum JR, Liu X, Dumot JA, Vargo J, Zuccarro G. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett’s esophagus with high-grade dysplasia and early cancer. Surgical Endoscopy. 2017;31(3):1336-1341. https://doi.org/10.1007/s00464-016-5117-1
Bartel MJ, Wallace TM, Gomez-Esquivel RD, Jang S, Lopez R, Goldblum JR, Liu X, Dumot JA, Vargo J, Zuccarro G. Role of EUS in patients with suspected Barrett’s esophagus with high-grade dysplasia or early esophageal adenocarcinoma: impact on endoscopic therapy. Gastrointestinal Endoscopy. 2017;86(2):292-298. https://doi.org/10.1016/j.gie.2016.11.016
Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. American Journal of Epidemiology. 2008;168(3):237-249. https://doi.org/10.1093/aje/kwn121
Anandasabapathy S, Sontag S, Graham DY, Frist S, Bratton J, Harpaz N, Waye JD. Computer-assisted brush-biopsy analysis for the detection of dysplasia in a high-risk Barrett’s esophagus surveillance population. Digestive Diseases and Sciences. 2011;56(3):761-766. https://doi.org/10.1007/s10620-010-1459-z
Eloubeidi MA, Tamhane A, Lopes TL, Morgan DE, Cerfolio RJ. Cervical esophageal perforations at the time of endoscopic ultrasound: a prospective evaluation of frequency, outcomes, and patient management. American Journal of Gastroenterology. 2009;104(1):53-56. https://doi.org/10.1038/ajg.2008.21
Das A, Sivak MV, Chak A. Cervical esophageal perforation during EUS: a national survey. Gastrointestinal Endoscopy. 2001;53(6):599-602. https://doi.org/10.1067/mge.2001.113385
Wang KX, Ben QW, Jin ZD, Du YQ, Zou DW, Liao Z, Li ZS. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointestinal Endoscopy. 2011;73(2):283-290. https://doi.org/10.1016/j.gie.2010.10.045
Yokoyama K, Ushio J, Numao N, Tamada K, Fukushima N, Lefor AK, Yamamoto H. Esophageal seeding after endoscopic ultrasound-guided fine-needle aspiration of a mediastinal tumor. Endoscopy International Open. 2017;5(9):E913-E917. https://doi.org/10.1055/s-0043-114662
Alzoubaidi D, Ragunath K, Wani S, Penman I, Trudgill N, Jansen M, Banks M, Bhandari P, Morris AJ, Willert R, Boger P, Smart HL, Ravi N, Dunn J, Gordon C, Mannath J, Mainie I, Pietro MD, Veitch A, Thorpe S, Magee C, Everson M, Sami S, Bassett P, Graham D, Attwood S, Pech O, Sharma P, Lovat LB, Haidry R. Quality indicators for Barrett’s endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett’s neoplasia. United European Gastroenterology. 2018;6:A37.
Bisschops R, Areia M, Coron E, Dobru D, Kaskas B, Kuvaev R, Pech O, Ragunath K, Weusten B, Familiari P, Domagk D, Valori R, Kaminski MF, Spada C, Bretthauer M, Bennett C, Senore C, Dinis-Ribeiro M, Rutter MD. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2016;48(9):843-864. https://doi.org/10.1055/s-0042-113128
Smith M, Ikonomi E, Bhuta R, Iorio N, Kataria RD, Kaul V, Gross SA, US Collaborative WATS Study Group. Wide area transepithelial sampling with computer-assisted 3-dimensional analysis (WATS(3D)) safely evaluates a variety of esophageal disorders. American Journal of Gastroenterology. 2014;109:S24 https://doi.org/10.14309/00000434-201410002-00066
Wolfsen HC, Sharma P, Wallace MB, Leggett C, Tearney G, Wang KK. Safety and feasibility of volumetric laser endomicroscopy in patients with Barrett’s esophagus (with videos). Gastrointestinal Endoscopy. 2015;82(4):631-640. https://doi.org/10.1016/j.gie.2015.03.1968
van der Sommen F, Klomp SR, Swager AF, Zinger S, Curvers WL, Bergman JJGHM, Schoon EJ, de With PHN. Predictive features for early cancer detection in Barrett’s esophagus using Volumetric Laser Endomicroscopy. Computerized Medical Imaging and Graphics. 2018;67:9-20. https://doi.org/10.1016/j.compmedimag.2018.02.007
Rodriguez MAC, de Moura DTH, Ribeiro IB, Bernardo WM, Morita FHA, Marques SB, Sakai P, de Moura EGH. Marginal Increase in Dysplasia Detection and Very High False Positive Rate for Volumetric Laser Endomicroscopy in Barrett’s Esophagus: Systemic Review and Meta-Analysis. Gastrointestinal Endoscopy. 2017;85(5):AB554. https://doi.org/10.1016/j.gie.2017.03.1279
Alshelleh M, Inamdar S, McKinley M, Stewart M, Novak JS, Greenberg RE, Sultan K, Devito B, Cheung M, Cerulli MA, Miller LS, Sejpal DV, Vegesna AK, Trindade AJ. Incremental yield of dysplasia detection in Barrett’s esophagus using volumetric laser endomicroscopy with and without laser marking compared with a standardized random biopsy protocol. Gastrointestinal Endoscopy. 2018;88(1):35-42. https://doi.org/10.1016/j.gie.2018.01.032
Swager AF, Faber DJ, de Bruin DM, Weusten BL, Meijer SL, Bergman J, Curvers WL, van Leeuwen TG. Quantitative attenuation analysis for identification of early Barrett’s neoplasia in volumetric laser endomicroscopy. Journal of Biomedical Optics. 2017;22(8):86001. https://doi.org/10.1117/1.JBO.22.8.086001
Leggett CL, Gorospe EC, Chan DK, Muppa P, Owens V, Smyrk TC, Anderson M, Lutzke LS, Tearney G, Wang KK. Comparative diagnostic performance of volumetric laser endomicroscopy and confocal laser endomicroscopy in the detection of dysplasia associated with Barrett’s esophagus. Gastrointestinal Endoscopy. 2016;83(5):880-888. https://doi.org/10.1016/j.gie.2015.08.050
Swager AF, van der Sommen F, Klomp SR, Zinger S, Meijer SL, Schoon EJ, Bergman JJGHM, de With PH, Curvers WL. Computer-aided detection of early Barrett’s neoplasia using volumetric laser endomicroscopy. Gastrointestinal Endoscopy. 2017;86(5):839-846. https://doi.org/10.1016/j.gie.2017.03.011
Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu A, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Thrift AP. Determining Risk of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology. 2018;154(5):1273-1281. https://doi.org/10.1053/j.gastro.2017.12.003
Thota PN, Chak A. Is Mass Screening for Barrett’s Esophagus a Myth or Reality? Clinical Gastroenterology and Hepatology. 2019;17(4):610-612. https://doi.org/10.1016/j.cgh.2018.09.026

Закрыть метаданные